Climb Bio (CLYM) Receivables - Accured (2021 - 2025)
Climb Bio (CLYM) posted Receivables - Accured of $1.4 million for Q1 2025, up 70.75% on a QoQ basis from $800000.0 in Q4 2024.
Climb Bio (CLYM) Receivables - Accured (2021 - 2025) Analysis & Trends
Climb Bio's Receivables - Accured history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2025.
- Quarterly Receivables - Accured changed N/A year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.4 million (changed N/A YoY) and the FY2024 annual result came in at $1.1 million, up 154.32% from the prior year.
- Receivables - Accured was $1.4 million for Q1 2025 at Climb Bio, up from $800000.0 in the prior quarter.
- Across five years, Receivables - Accured topped out at $1.4 million in Q1 2025 and bottomed at $100000.0 in Q4 2022.
- A 5-year average of $442769.2 and a median of $300000.0 in 2021 frame the typical range for Receivables - Accured.
- Annual changes were most pronounced in 2022 — Receivables - Accured sank 80.0% — and 2023, when it jumped 300.0%.
- Climb Bio's Receivables - Accured stood at $500000.0 in 2021, then sank by 80.0% to $100000.0 in 2022, then soared by 300.0% to $400000.0 in 2023, then jumped by 100.0% to $800000.0 in 2024, then jumped by 70.75% to $1.4 million in 2025.
- Business Quant data shows CLYM's Receivables - Accured at $1.4 million in Q1 2025, $800000.0 in Q4 2024, and $990000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 800,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 990,000.00 |
| Sep 30, 2024 | 990,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |